Journal News

Omics study unveils molecular mechanisms of a parasitic infection

Jaclyn Brennan-McLean
May 25, 2021

Paramphistomes, also known as rumen or stomach fluke, are flatworm parasites that infect sheep and cattle in temperate and tropical regions. In recent years, the incidence and severity of rumen fluke infections (specifically the paramphistome Calicophoron daubneyi) have increased sharply in Western Europe. Heavy infections of immature rumen fluke in the small intestine can lead to hemorrhaging and even death, so early detection and correct diagnosis are imperative. However, researchers still know little about the biology of C. daubneyi and its effects on host animals.

Mark Robinson's lab at Queen's University Belfast focuses on parasitic worms and how they interact with their hosts at the molecular level. He has studied liver fluke for over 20 years. With the recent emergence of the less-studied rumen fluke in Europe (particularly in Northern Ireland, where his lab is based), his latest work shifted to understanding this unusual parasite and its host interactions. His findings, published in the journal Molecular & Cellular Proteomics, show how C. daubneyiregulates expression and secretion of certain molecules to establish infection, feed on host tissue and fight off the host immune response in ruminant livestock.

MCP-rumen-fluke-445x344.jpg
Robinson lab / Queen's University Belfast
This illustration shows the development of the rumen fluke Calicophoron daubneyi. In a recent study, secretome profiling revealed distinct families of virulence factors and immunomodulators associated with acute and chronic infection.

To begin to investigate the molecular biology of rumen fluke, Robinson's group teamed up with other researchers from the United Kingdom. Together, they performed transcriptome analysis of four rumen fluke life-cycle stages and integrated these results with proteomic analysis of secretions from two of these stages. They picked the juvenile flukes and mature adult stages for the proteomics studies, as these are the key stages responsible for acute and chronic disease, respectively.

Juvenile flukes emerge in the small intestine and eventually migrate along the digestive tract to the rumen, where they mature into adults. During each stage, the parasite must adapt to drastic changes in the host microenvironment and counter inevitable attacks by the host immune system. According to Robinson's findings, they do so easily.

"The rumen fluid is like a soup of bacteria and protozoans which the flukes must live amongst and survive," Robinson said.

Rumen flukes appear to secrete certain molecules that help them establish and maintain infection within this challenging host environment. Robinson likens the protective properties of these secreted molecules to those of the garments worn by astronauts: "Imagine stepping onto the surface of the moon without a space suit — you wouldn't last very long. Same goes for flukes within their host environments without their shield of secreted molecules."

Robinson believes the host–parasite interface can be adjusted to fight off infection. "If we can devise ways of blocking the secreted molecules, which are so important for the parasite, we may be able to come up with new treatment options," he said.

The lab has developed the first enzyme-linked immunosorbent assay for C. daubneyi, which they hope can be used by veterinarians, animal producers and farmers for disease surveillance and diagnosis. Next, Robinson wants to perform functional studies to validate certain molecules as targets for fluke control. As with all the work done in his lab, these efforts center on improving animal health and welfare, which he says is of benefit to everyone.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jaclyn Brennan-McLean

Jaclyn Brennan-McLean earned her Ph.D. in biomedical engineering from George Washington University in 2020 with a research focus in cardiac electrophysiology. She is a 2022-2023 AAAS Science & Technology Policy fellow.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mapping the placenta’s hormone network
Journal News

Mapping the placenta’s hormone network

Oct. 21, 2025

Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
News

Biochemists and molecular biologists sweep major 2025 honors

Oct. 20, 2025

Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.

Spider-like proteins spin defenses to control immunity
News

Spider-like proteins spin defenses to control immunity

Oct. 17, 2025

Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.